2020
R. Cardoso, Lemos, C., Oliveiros, B., Almeida, M. Rosário, Baldeiras, I., Pereira, C. Fragão, Santos, A., Duro, D., Vieira, D., Santana, I., and Oliveira, C. Resende,
“APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.”,
J Alzheimers Dis, vol. 78, no. 2, pp. 587-601, 2020.
N. Boublay, Bouet, R., Dorey, J. - M., Padovan, C., Makaroff, Z., Federico, D., Gallice, I., Barrellon, M. - O., Robert, P., Moreaud, O., Rouch, I., and Krolak-Salmon, P.,
“Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 73, no. 4, pp. 1343-1353, 2020.
A. M. Mezlini, Magdamo, C., Merrill, E., Chibnik, L. B., Blacker, D. L., Hyman, B. T., and Das, S.,
“Characterizing Clinical and Neuropathological Traits of APOE Haplotypes in African Americans and Europeans.”,
J Alzheimers Dis, vol. 78, no. 1, pp. 467-477, 2020.
R. Muzambi, Bhaskaran, K., Brayne, C., Davidson, J. A., Smeeth, L., and Warren-Gash, C.,
“Common Bacterial Infections and Risk of Dementia or Cognitive Decline: A Systematic Review.”,
J Alzheimers Dis, vol. 76, no. 4, pp. 1609-1626, 2020.
Y. Xia, Yassi, N., Raniga, P., Bourgeat, P., Desmond, P., Doecke, J., Ames, D., Laws, S. M., Fowler, C., Rainey-Smith, S. R., Martins, R., Maruff, P., Villemagne, V. L., Masters, C. L., Rowe, C. C., Fripp, J., and Salvado, O.,
“Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.”,
J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
Y. Xia, Yassi, N., Raniga, P., Bourgeat, P., Desmond, P., Doecke, J., Ames, D., Laws, S. M., Fowler, C., Rainey-Smith, S. R., Martins, R., Maruff, P., Villemagne, V. L., Masters, C. L., Rowe, C. C., Fripp, J., and Salvado, O.,
“Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.”,
J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
M. Bisbe, Fuente-Vidal, A., López, E., Moreno, M., Naya, M., de Benetti, C., Milà, R., Bruna, O., Boada, M., and Alegret, M.,
“Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial.”,
J Alzheimers Dis, vol. 73, no. 2, pp. 769-783, 2020.
D. Caligiore, Silvetti, M., D'Amelio, M., Puglisi-Allegra, S., and Baldassarre, G.,
“Computational Modeling of Catecholamines Dysfunction in Alzheimer's Disease at Pre-Plaque Stage.”,
J Alzheimers Dis, vol. 77, no. 1, pp. 275-290, 2020.
A. C. Robinson, Roncaroli, F., Chew-Graham, S., Davidson, Y. S., Minshull, J., Horan, M. A., Payton, A., Pendleton, N., and Mann, D. M. A.,
“The Contribution of Vascular Pathology Toward Cognitive Impairment in Older Individuals with Intermediate Braak Stage Tau Pathology.”,
J Alzheimers Dis, vol. 77, no. 3, pp. 1005-1015, 2020.
R. A. A. de Heus, Reumers, S. F. I., van der Have, A., Tumelaire, M., Tully, P. J., and Claassen, J. A. H. R.,
“Day-to-Day Home Blood Pressure Variability is Associated with Cerebral Small Vessel Disease Burden in a Memory Clinic Population.”,
J Alzheimers Dis, vol. 74, no. 2, pp. 463-472, 2020.
L. Shi, Winchester, L. M., Liu, B. Y., Killick, R., Ribe, E. M., Westwood, S., Baird, A. L., Buckley, N. J., Hong, S., Dobricic, V., Kilpert, F., Franke, A., Kiddle, S., Sattlecker, M., Dobson, R., Cuadrado, A., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Kate, M. Ten, Scheltens, P., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Alcolea, D., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Teunissen, C. E., Freund-Levi, Y., Frölich, L., Legido-Quigley, C., Barkhof, F., Blennow, K., Rasmussen, K. Laura, Nordestgaard, B. Grønne, Frikke-Schmidt, R., Nielsen, S. Fallgaard, Soininen, H., Vellas, B., Kloszewska, I., Mecocci, P., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, Bertram, L., Nevado-Holgado, A. J., and Lovestone, S.,
“Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”,
J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
L. Shi, Winchester, L. M., Liu, B. Y., Killick, R., Ribe, E. M., Westwood, S., Baird, A. L., Buckley, N. J., Hong, S., Dobricic, V., Kilpert, F., Franke, A., Kiddle, S., Sattlecker, M., Dobson, R., Cuadrado, A., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Kate, M. Ten, Scheltens, P., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Alcolea, D., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Teunissen, C. E., Freund-Levi, Y., Frölich, L., Legido-Quigley, C., Barkhof, F., Blennow, K., Rasmussen, K. Laura, Nordestgaard, B. Grønne, Frikke-Schmidt, R., Nielsen, S. Fallgaard, Soininen, H., Vellas, B., Kloszewska, I., Mecocci, P., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, Bertram, L., Nevado-Holgado, A. J., and Lovestone, S.,
“Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”,
J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
L. Shi, Winchester, L. M., Liu, B. Y., Killick, R., Ribe, E. M., Westwood, S., Baird, A. L., Buckley, N. J., Hong, S., Dobricic, V., Kilpert, F., Franke, A., Kiddle, S., Sattlecker, M., Dobson, R., Cuadrado, A., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Kate, M. Ten, Scheltens, P., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Alcolea, D., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Teunissen, C. E., Freund-Levi, Y., Frölich, L., Legido-Quigley, C., Barkhof, F., Blennow, K., Rasmussen, K. Laura, Nordestgaard, B. Grønne, Frikke-Schmidt, R., Nielsen, S. Fallgaard, Soininen, H., Vellas, B., Kloszewska, I., Mecocci, P., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, Bertram, L., Nevado-Holgado, A. J., and Lovestone, S.,
“Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”,
J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
W. E Mehling, M Scott, T., Duffy, J., A Whitmer, R., A Chesney, M., W Boscardin, J., and E Barnes, D.,
“Dyadic Group Exercises for Persons with Memory Deficits and Care Partners: Mixed-Method Findings from the Paired Preventing Loss of Independence through Exercise (PLIÉ) Randomized Trial.”,
J Alzheimers Dis, vol. 78, no. 4, pp. 1689-1706, 2020.
C. Boutoleau-Bretonnière, Pouclet-Courtemanche, H., Gillet, A., Bernard, A., Deruet, A. Laure, Gouraud, I., Mazoue, A., Lamy, E., Rocher, L., Kapogiannis, D., and Haj, M. El,
“The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.”,
J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
H. Kaur, Golovko, S., Golovko, M. Y., Singh, S., Darland, D. C., and Combs, C. K.,
“Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 76, no. 3, pp. 1083-1102, 2020.
L. Calderón-Garcidueñas, Torres-Jardón, R., Franco-Lira, M., Kulesza, R., González-Maciel, A., Reynoso-Robles, R., Brito-Aguilar, R., García-Arreola, B., Revueltas-Ficachi, P., Barrera-Velázquez, J. Adriana, García-Alonso, G., García-Rojas, E., Mukherjee, P. S., and Delgado-Chávez, R.,
“Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”,
J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
D. Arnaldi, Donniaquio, A., Mattioli, P., Massa, F., Grazzini, M., Meli, R., Filippi, L., Grisanti, S., Famá, F., Terzaghi, M., Girtler, N., Brugnolo, A., Doglione, E., Pardini, M., Villani, F., and Nobili, F.,
“Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.”,
J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
D. Arnaldi, Donniaquio, A., Mattioli, P., Massa, F., Grazzini, M., Meli, R., Filippi, L., Grisanti, S., Famá, F., Terzaghi, M., Girtler, N., Brugnolo, A., Doglione, E., Pardini, M., Villani, F., and Nobili, F.,
“Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.”,
J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
S. Chamberlain, Gabriel, H., Strittmatter, W., and Didsbury, J.,
“An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease.”,
J Alzheimers Dis, vol. 73, no. 3, pp. 1085-1103, 2020.
M. Roy, Rheault, F., Croteau, E., Castellano, C. - A., Fortier, M., St-Pierre, V., Houde, J. - C., Turcotte, É. E., Bocti, C., Fülöp, T., Cunnane, S. C., and Descoteaux, M.,
“Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 76, no. 3, pp. 863-881, 2020.
S. Schwab, Afyouni, S., Chen, Y., Han, Z., Guo, Q., Dierks, T., Wahlund, L. - O., and Grieder, M.,
“Functional Connectivity Alterations of the Temporal Lobe and Hippocampus in Semantic Dementia and Alzheimer's Disease.”,
J Alzheimers Dis, vol. 76, no. 4, pp. 1461-1475, 2020.
M. Muurling, Rhodius-Meester, H. F. M., Pärkkä, J., van Gils, M., Frederiksen, K. S., Bruun, M., Hasselbalch, S. G., Soininen, H., Herukka, S. - K., Hallikainen, M., Teunissen, C. E., Visser, P. Jelle, Scheltens, P., van der Flier, W. M., Mattila, J., Lötjönen, J., and de Boer, C.,
“Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”,
J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
H. Jang, Kim, H. Jin, Choe, Y. Sim, Kim, S. - J., Park, S., Kim, Y., Kim, K. Woon, Lyoo, C. Hyoung, Cho, H., Ryu, Y. Hoon, Choi, J. Yong, DeCarli, C., Na, D. L., and Seo, S. Won,
“The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.”,
J Alzheimers Dis, vol. 78, no. 2, pp. 573-585, 2020.
E. J. Davidowitz, Krishnamurthy, P. K., Lopez, P., Jimenez, H., Adrien, L., Davies, P., and Moe, J. G.,
“In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.”,
J Alzheimers Dis, vol. 73, no. 1, pp. 147-161, 2020.
] 